The ERT System: Present Position and Objectives

 
 
 

 
 

The ERT System: Present Position and Objectives

During the EUROTOX 2011 Paris Congress on August 29, 2011, a Workshop on “THE EUROTOX REGISTRATION/ERT SYSTEM: PRESENT POSITION AND OBJECTIVES” was held.

The Program of the Workshop: THE EUROTOX REGISTRATION/ERT SYSTEM: PRESENT POSITION AND OBJECTIVES
(To learn more about the program download the pesentations)
 

  1. The current position of EUROTOX registration/ERT system.
    M. Iscan

    Department of Toxicology, Faculty of Pharmacy, Ankara University, Ankara-Turkey
     
  2. Role of peer review boards and mentors.
    J. S. L. Fowler1, M. Iscan2, R. Schulte-Hermann3
    1
    Research & Liasion, John Lawrence Associates LTD., London, UK
    2 Department of Toxicology, Faculty of Pharmacy, Ankara University, Ankara-Turkey
    3 Institute of Cancer Research, Medical University of Vienna, Vienna, Austria
     
  3. Risk Assessment Training and ERTs.
    C. L. Galli, Italy
    University of Milan, Milan, Italy.
     
  4. The core of ERT : Qualification of an Expert in Toxicology in National training programs
    H. Foth1, R. Schulte-Hermann2
    1
    Martin Luther University, Halle, Saale, Germany
    2Institute of Cancer Research, Medical University of Vienna, Vienna, Austria
     
  5. Professional recognition and credibility of ERTs across Europe. How to leverage?
    R. A. Roberts, L. Cornes
    AstraZeneca R&D, Macclesfield, UK.
     
  6. Challenges : How to overcome them?
    H. Autrup
    University of Aarhus, Aarhus, Denmark